EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3
| Autor: | Raje, N a, Leleu, X b, Lesokhin, A c, Mohty, M d, Nooka, A e, Leip, E f, Conte, U g, Viqueira, A h, Blunk, V i, Manier, S j |
|---|---|
| Zdroj: | In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S406-S407 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|